A carregar...
Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
BACKGROUND: Tamoxifen (TAM) is used in breast cancer treatment, but interindividual variabilities in TAM-metabolizing enzymes exist and have been linked to single nucleotide polymorphisms in the respective encoding genes. The different alleles and genotypes of these genes have been presented for Cau...
Na minha lista:
| Publicado no: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4982506/ https://ncbi.nlm.nih.gov/pubmed/27540311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S105563 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|